Figure 5.
Mapping of the prostate cancer proteome in EV-enriched fractions. LC-MS/MS data from EV-enriched fractions from prostate cancer patients pre- and post-treatment are compared by (a) principle component analysis and (b) volcano plot analysis. Proteins related to prostate (pre-treatment) and bladder and kidney (post-treatment) tissue are highlighted. (c) LC-MS/MS data from EV-enriched fractions from patients with benign prostatic hyperplasia (BPH) and prostate cancer (PC) as compared by principle component analysis. (d) Venn diagram displaying EV-enriched proteins enriched in prostate cancer EV prior to treatment versus after treatment and versus benign prostatic hyperplasia.